These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20967845)

  • 1. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.
    Sanders DB; Bittner RC; Rosenfeld M; Redding GJ; Goss CH
    Pediatr Pulmonol; 2011 Apr; 46(4):393-400. PubMed ID: 20967845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
    Waters V; Stanojevic S; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    Eur Respir J; 2012 Jul; 40(1):61-6. PubMed ID: 22135280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis.
    Sanders DB; Hoffman LR; Emerson J; Gibson RL; Rosenfeld M; Redding GJ; Goss CH
    Pediatr Pulmonol; 2010 Feb; 45(2):127-34. PubMed ID: 20054859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
    Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
    J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
    Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V
    Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
    de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
    Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.
    Wells JM; Farris RF; Gosdin TA; Dransfield MT; Wood ME; Bell SC; Rowe SM
    Lancet Respir Med; 2016 Aug; 4(8):636-645. PubMed ID: 27298019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis.
    Cousin M; Molinari N; Foulongne V; Caimmi D; Vachier I; Abely M; Chiron R
    Influenza Other Respir Viruses; 2016 Mar; 10(2):109-12. PubMed ID: 26493783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.
    Sanders DB; Bittner RC; Rosenfeld M; Hoffman LR; Redding GJ; Goss CH
    Am J Respir Crit Care Med; 2010 Sep; 182(5):627-32. PubMed ID: 20463179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.
    Konstan MW; Wagener JS; Pasta DJ; Millar SJ; Jacobs JR; Yegin A; Morgan WJ;
    Pediatr Pulmonol; 2011 Jun; 46(6):545-53. PubMed ID: 21438174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying Long-Term Changes in Lung Function and Exacerbations after Initiation of Azithromycin in Cystic Fibrosis.
    Denis A; Touzet S; Diabaté L; Durieu I; Lemonnier L; Poupon-Bourdy S; Iwaz J; Reynaud Q; Rabilloud M
    Ann Am Thorac Soc; 2020 Feb; 17(2):195-201. PubMed ID: 31604024
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiotic duration and changes in FEV
    Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
    BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for lung disease progression in children with cystic fibrosis.
    van Horck M; van de Kant K; Winkens B; Wesseling G; Gulmans V; Hendriks H; van der Grinten C; Jöbsis Q; Dompeling E
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29773689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
    Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
    J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of computed tomography scoring systems evolution in adults with cystic fibrosis.
    Zorzo C; Caballero P; Diab L; Pastor MT; Gómez-Punter RM; Girón RM
    Eur Radiol; 2020 Jul; 30(7):3634-3640. PubMed ID: 32128619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative chest computerized tomography and FEV
    Sanders DB; Li Z; Parker-McGill K; Farrell P; Brody AS
    Pediatr Pulmonol; 2018 Oct; 53(10):1369-1377. PubMed ID: 30160050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes.
    Collaco JM; Green DM; Cutting GR; Naughton KM; Mogayzel PJ
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1137-43. PubMed ID: 20581166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.
    Lechtzin N; Mayer-Hamblett N; West NE; Allgood S; Wilhelm E; Khan U; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Gibson RL; Orenstein D; Milla C; Clancy JP; Antony V; Goss CH;
    Am J Respir Crit Care Med; 2017 Nov; 196(9):1144-1151. PubMed ID: 28608719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.